大规模的临床试验和药物管道:即将到来的海
1Sherrie & Alan Conover Center for Liver Disease & Transplantation, Underwood Center for Digestive Disorders Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.
Hepatology (Baltimore, Md.)
|March 19, 2024
概括
代谢功能障碍相关的脂肪肝炎 (MASH) 研究正在迅速推进,预计第一种药物将在2024年获得批准. 本综述涵盖了当前的MASH药物机制,试验终点和未来治疗的挑战.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD),以前称为NAFLD,是日益蔓延的流行病和肝移植的主要原因.
- 它的高级形式,MASH,可以发展为肝硬化,肝癌和衰竭.
- 尽管进行了广泛的研究,但目前还没有批准的药物存在,但预计将在2024年获得批准.
研究的目的:
- 审查MASH药物研究的现状,包括机制,结果和未来方向.
- 讨论MASH临床试验中的挑战,并提出解决方案.
- 突出MASH药物开发的不断变化的监管终点.
主要方法:
- 对MASH疗法的当前科学文献和临床试验数据的审查.
- 对正在调查的各种药物点和途径的分析.
- 对MASH药物疗效的监管终点的检查.
主要成果:
- 目前正在探索多种治疗途径,包括准甲状腺激素受体,GLP-1和PPARs.
- 关键的监管终点侧重于MASH解决或纤维化改善.
- 组合疗法正在成为一个有前途的战略.
结论:
- 麻氏药物开发领域正在迅速向第一批批准的疗法发展.
- 克服临床试验设计和终点选择中的挑战至关重要.
- 未来的研究可能会专注于组合疗法,以获得全面的患者益处.
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Drug Administration and Therapy Phases: Overview
460
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
460
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K


